Practice
Update to living WHO guideline on drugs for covid-19
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4779 (Published 17 December 2020) Cite this as: BMJ 2020;371:m4779
This living guideline by Lamontagne and colleagues (BMJ 2020;370:m3379) has been updated. For the latest update, visit doi:10.1136/bmj.m3379. The latest version of this WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with covid-19 regardless of disease severity. These recommendations follow the publication of results from the WHO SOLIDARITY trial.